 | • レポートコード：MRC2312MG05710 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の薬局研究用ワンストップCDMO市場規模と予測を収録しています。・世界の薬局研究用ワンストップCDMO市場：売上、2018年-2023年、2024年-2029年 ・世界の薬局研究用ワンストップCDMO市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の薬局研究用ワンストップCDMO市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「API+調剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 薬局研究用ワンストップCDMOのグローバル主要企業は、Medicilon、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Langhua Pharmaceutical、 Viva Biotech、 Zhejiang Jiuzhou Pharmaceutical、 Shanghai Porton Zhihui Biopharmaceutical、 Boji Pharmaceutical Technology、 GenScript ProBio、 Asymchem Laboratories (Tianjin)、 Beijing Sun-novo Pharmaceutical Research、 Arthur Pharmaなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、薬局研究用ワンストップCDMOのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の薬局研究用ワンストップCDMO市場：タイプ別、2018年-2023年、2024年-2029年 世界の薬局研究用ワンストップCDMO市場：タイプ別市場シェア、2022年 ・API+調剤、API+中間+調剤 世界の薬局研究用ワンストップCDMO市場：用途別、2018年-2023年、2024年-2029年 世界の薬局研究用ワンストップCDMO市場：用途別市場シェア、2022年 ・革新的医薬品、ジェネリック医薬品、改良医薬品、その他 世界の薬局研究用ワンストップCDMO市場：地域・国別、2018年-2023年、2024年-2029年 世界の薬局研究用ワンストップCDMO市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における薬局研究用ワンストップCDMOのグローバル売上、2018年-2023年 ・主要企業における薬局研究用ワンストップCDMOのグローバル売上シェア、2022年 ・主要企業における薬局研究用ワンストップCDMOのグローバル販売量、2018年-2023年 ・主要企業における薬局研究用ワンストップCDMOのグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Medicilon、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Langhua Pharmaceutical、 Viva Biotech、 Zhejiang Jiuzhou Pharmaceutical、 Shanghai Porton Zhihui Biopharmaceutical、 Boji Pharmaceutical Technology、 GenScript ProBio、 Asymchem Laboratories (Tianjin)、 Beijing Sun-novo Pharmaceutical Research、 Arthur Pharma ************************************************************* ・調査・分析レポートの概要 薬局研究用ワンストップCDMO市場の定義 市場セグメント 世界の薬局研究用ワンストップCDMO市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の薬局研究用ワンストップCDMO市場規模 世界の薬局研究用ワンストップCDMO市場規模：2022年 VS 2029年 世界の薬局研究用ワンストップCDMO市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの薬局研究用ワンストップCDMOの売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の薬局研究用ワンストップCDMO製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：API+調剤、API+中間+調剤 薬局研究用ワンストップCDMOのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：革新的医薬品、ジェネリック医薬品、改良医薬品、その他 薬局研究用ワンストップCDMOの用途別グローバル売上・予測 ・地域別市場分析 地域別薬局研究用ワンストップCDMO市場規模 2022年と2029年 地域別薬局研究用ワンストップCDMO売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Medicilon、 Gliead、 Boehringer Ingelheim、 Vertex、 Mirati Therapeutics、 AMPAC、 Pfizer、 Polypeptide、 Bachem、 Merck、 Asymchem、 Zhejiang Langhua Pharmaceutical、 Viva Biotech、 Zhejiang Jiuzhou Pharmaceutical、 Shanghai Porton Zhihui Biopharmaceutical、 Boji Pharmaceutical Technology、 GenScript ProBio、 Asymchem Laboratories (Tianjin)、 Beijing Sun-novo Pharmaceutical Research、 Arthur Pharma ... |
This research report provides a comprehensive analysis of the One-stop Pharmacy Research CDMO market, focusing on the current trends, market dynamics, and future prospects. The report explores the global One-stop Pharmacy Research CDMO market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of One-stop Pharmacy Research CDMO, challenges faced by the industry, and potential opportunities for market players.
The global One-stop Pharmacy Research CDMO market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The One-stop Pharmacy Research CDMO market presents opportunities for various stakeholders, including Innovative Drugs, Generic Drugs. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in One-stop Pharmacy Research CDMO market. Additionally, the growing consumer demand present avenues for market expansion.
The global One-stop Pharmacy Research CDMO market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
A one-stop pharmacy research CDMO usually covers the following services: drug discovery, pharmacological research, drug formulation development, synthesis and analytical method development, adverse event reporting and monitoring, pre-clinical trial research, GMP manufacturing. By providing a full range of pharmaceutical research services, the one-stop pharmacy research CDMO can help pharmaceutical companies shorten the R&D cycle, reduce R&D costs, improve product quality, and provide integrated solutions to provide comprehensive support for the R&D work of pharmaceutical companies.
Key Features:
The research report on the One-stop Pharmacy Research CDMO market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the One-stop Pharmacy Research CDMO market.
Market Overview: The report provides a comprehensive overview of the One-stop Pharmacy Research CDMO market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., API+Preparation, API+Intermediate+Preparation), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the One-stop Pharmacy Research CDMO market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the One-stop Pharmacy Research CDMO market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the One-stop Pharmacy Research CDMO market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the One-stop Pharmacy Research CDMO market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the One-stop Pharmacy Research CDMO market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the One-stop Pharmacy Research CDMO market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for One-stop Pharmacy Research CDMO, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the One-stop Pharmacy Research CDMO market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
One-stop Pharmacy Research CDMO market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
API+Preparation
API+Intermediate+Preparation
Market segment by Application
Innovative Drugs
Generic Drugs
Improved Drugs
Others
Global One-stop Pharmacy Research CDMO Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Medicilon
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Langhua Pharmaceutical
Viva Biotech
Zhejiang Jiuzhou Pharmaceutical
Shanghai Porton Zhihui Biopharmaceutical
Boji Pharmaceutical Technology
GenScript ProBio
Asymchem Laboratories (Tianjin)
Beijing Sun-novo Pharmaceutical Research
Arthur Pharma
Outline of Major Chapters:
Chapter 1: Introduces the definition of One-stop Pharmacy Research CDMO, market overview.
Chapter 2: Global One-stop Pharmacy Research CDMO market size in revenue.
Chapter 3: Detailed analysis of One-stop Pharmacy Research CDMO company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of One-stop Pharmacy Research CDMO in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 One-stop Pharmacy Research CDMO Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global One-stop Pharmacy Research CDMO Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global One-stop Pharmacy Research CDMO Overall Market Size
2.1 Global One-stop Pharmacy Research CDMO Market Size: 2022 VS 2029
2.2 Global One-stop Pharmacy Research CDMO Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top One-stop Pharmacy Research CDMO Players in Global Market
3.2 Top Global One-stop Pharmacy Research CDMO Companies Ranked by Revenue
3.3 Global One-stop Pharmacy Research CDMO Revenue by Companies
3.4 Top 3 and Top 5 One-stop Pharmacy Research CDMO Companies in Global Market, by Revenue in 2022
3.5 Global Companies One-stop Pharmacy Research CDMO Product Type
3.6 Tier 1, Tier 2 and Tier 3 One-stop Pharmacy Research CDMO Players in Global Market
3.6.1 List of Global Tier 1 One-stop Pharmacy Research CDMO Companies
3.6.2 List of Global Tier 2 and Tier 3 One-stop Pharmacy Research CDMO Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global One-stop Pharmacy Research CDMO Market Size Markets, 2022 & 2029
4.1.2 API+Preparation
4.1.3 API+Intermediate+Preparation
4.2 By Type – Global One-stop Pharmacy Research CDMO Revenue & Forecasts
4.2.1 By Type – Global One-stop Pharmacy Research CDMO Revenue, 2018-2023
4.2.2 By Type – Global One-stop Pharmacy Research CDMO Revenue, 2024-2029
4.2.3 By Type – Global One-stop Pharmacy Research CDMO Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global One-stop Pharmacy Research CDMO Market Size, 2022 & 2029
5.1.2 Innovative Drugs
5.1.3 Generic Drugs
5.1.4 Improved Drugs
5.1.5 Others
5.2 By Application – Global One-stop Pharmacy Research CDMO Revenue & Forecasts
5.2.1 By Application – Global One-stop Pharmacy Research CDMO Revenue, 2018-2023
5.2.2 By Application – Global One-stop Pharmacy Research CDMO Revenue, 2024-2029
5.2.3 By Application – Global One-stop Pharmacy Research CDMO Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global One-stop Pharmacy Research CDMO Market Size, 2022 & 2029
6.2 By Region – Global One-stop Pharmacy Research CDMO Revenue & Forecasts
6.2.1 By Region – Global One-stop Pharmacy Research CDMO Revenue, 2018-2023
6.2.2 By Region – Global One-stop Pharmacy Research CDMO Revenue, 2024-2029
6.2.3 By Region – Global One-stop Pharmacy Research CDMO Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America One-stop Pharmacy Research CDMO Revenue, 2018-2029
6.3.2 US One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.3.3 Canada One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.3.4 Mexico One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe One-stop Pharmacy Research CDMO Revenue, 2018-2029
6.4.2 Germany One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.4.3 France One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.4.4 U.K. One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.4.5 Italy One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.4.6 Russia One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.4.7 Nordic Countries One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.4.8 Benelux One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia One-stop Pharmacy Research CDMO Revenue, 2018-2029
6.5.2 China One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.5.3 Japan One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.5.4 South Korea One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.5.5 Southeast Asia One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.5.6 India One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America One-stop Pharmacy Research CDMO Revenue, 2018-2029
6.6.2 Brazil One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.6.3 Argentina One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa One-stop Pharmacy Research CDMO Revenue, 2018-2029
6.7.2 Turkey One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.7.3 Israel One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.7.4 Saudi Arabia One-stop Pharmacy Research CDMO Market Size, 2018-2029
6.7.5 UAE One-stop Pharmacy Research CDMO Market Size, 2018-2029
7 One-stop Pharmacy Research CDMO Companies Profiles
7.1 Medicilon
7.1.1 Medicilon Company Summary
7.1.2 Medicilon Business Overview
7.1.3 Medicilon One-stop Pharmacy Research CDMO Major Product Offerings
7.1.4 Medicilon One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.1.5 Medicilon Key News & Latest Developments
7.2 Gliead
7.2.1 Gliead Company Summary
7.2.2 Gliead Business Overview
7.2.3 Gliead One-stop Pharmacy Research CDMO Major Product Offerings
7.2.4 Gliead One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.2.5 Gliead Key News & Latest Developments
7.3 Boehringer Ingelheim
7.3.1 Boehringer Ingelheim Company Summary
7.3.2 Boehringer Ingelheim Business Overview
7.3.3 Boehringer Ingelheim One-stop Pharmacy Research CDMO Major Product Offerings
7.3.4 Boehringer Ingelheim One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.3.5 Boehringer Ingelheim Key News & Latest Developments
7.4 Vertex
7.4.1 Vertex Company Summary
7.4.2 Vertex Business Overview
7.4.3 Vertex One-stop Pharmacy Research CDMO Major Product Offerings
7.4.4 Vertex One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.4.5 Vertex Key News & Latest Developments
7.5 Mirati Therapeutics
7.5.1 Mirati Therapeutics Company Summary
7.5.2 Mirati Therapeutics Business Overview
7.5.3 Mirati Therapeutics One-stop Pharmacy Research CDMO Major Product Offerings
7.5.4 Mirati Therapeutics One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.5.5 Mirati Therapeutics Key News & Latest Developments
7.6 AMPAC
7.6.1 AMPAC Company Summary
7.6.2 AMPAC Business Overview
7.6.3 AMPAC One-stop Pharmacy Research CDMO Major Product Offerings
7.6.4 AMPAC One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.6.5 AMPAC Key News & Latest Developments
7.7 Pfizer
7.7.1 Pfizer Company Summary
7.7.2 Pfizer Business Overview
7.7.3 Pfizer One-stop Pharmacy Research CDMO Major Product Offerings
7.7.4 Pfizer One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.7.5 Pfizer Key News & Latest Developments
7.8 Polypeptide
7.8.1 Polypeptide Company Summary
7.8.2 Polypeptide Business Overview
7.8.3 Polypeptide One-stop Pharmacy Research CDMO Major Product Offerings
7.8.4 Polypeptide One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.8.5 Polypeptide Key News & Latest Developments
7.9 Bachem
7.9.1 Bachem Company Summary
7.9.2 Bachem Business Overview
7.9.3 Bachem One-stop Pharmacy Research CDMO Major Product Offerings
7.9.4 Bachem One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.9.5 Bachem Key News & Latest Developments
7.10 Merck
7.10.1 Merck Company Summary
7.10.2 Merck Business Overview
7.10.3 Merck One-stop Pharmacy Research CDMO Major Product Offerings
7.10.4 Merck One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.10.5 Merck Key News & Latest Developments
7.11 Asymchem
7.11.1 Asymchem Company Summary
7.11.2 Asymchem Business Overview
7.11.3 Asymchem One-stop Pharmacy Research CDMO Major Product Offerings
7.11.4 Asymchem One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.11.5 Asymchem Key News & Latest Developments
7.12 Zhejiang Langhua Pharmaceutical
7.12.1 Zhejiang Langhua Pharmaceutical Company Summary
7.12.2 Zhejiang Langhua Pharmaceutical Business Overview
7.12.3 Zhejiang Langhua Pharmaceutical One-stop Pharmacy Research CDMO Major Product Offerings
7.12.4 Zhejiang Langhua Pharmaceutical One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.12.5 Zhejiang Langhua Pharmaceutical Key News & Latest Developments
7.13 Viva Biotech
7.13.1 Viva Biotech Company Summary
7.13.2 Viva Biotech Business Overview
7.13.3 Viva Biotech One-stop Pharmacy Research CDMO Major Product Offerings
7.13.4 Viva Biotech One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.13.5 Viva Biotech Key News & Latest Developments
7.14 Zhejiang Jiuzhou Pharmaceutical
7.14.1 Zhejiang Jiuzhou Pharmaceutical Company Summary
7.14.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
7.14.3 Zhejiang Jiuzhou Pharmaceutical One-stop Pharmacy Research CDMO Major Product Offerings
7.14.4 Zhejiang Jiuzhou Pharmaceutical One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.14.5 Zhejiang Jiuzhou Pharmaceutical Key News & Latest Developments
7.15 Shanghai Porton Zhihui Biopharmaceutical
7.15.1 Shanghai Porton Zhihui Biopharmaceutical Company Summary
7.15.2 Shanghai Porton Zhihui Biopharmaceutical Business Overview
7.15.3 Shanghai Porton Zhihui Biopharmaceutical One-stop Pharmacy Research CDMO Major Product Offerings
7.15.4 Shanghai Porton Zhihui Biopharmaceutical One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.15.5 Shanghai Porton Zhihui Biopharmaceutical Key News & Latest Developments
7.16 Boji Pharmaceutical Technology
7.16.1 Boji Pharmaceutical Technology Company Summary
7.16.2 Boji Pharmaceutical Technology Business Overview
7.16.3 Boji Pharmaceutical Technology One-stop Pharmacy Research CDMO Major Product Offerings
7.16.4 Boji Pharmaceutical Technology One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.16.5 Boji Pharmaceutical Technology Key News & Latest Developments
7.17 GenScript ProBio
7.17.1 GenScript ProBio Company Summary
7.17.2 GenScript ProBio Business Overview
7.17.3 GenScript ProBio One-stop Pharmacy Research CDMO Major Product Offerings
7.17.4 GenScript ProBio One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.17.5 GenScript ProBio Key News & Latest Developments
7.18 Asymchem Laboratories (Tianjin)
7.18.1 Asymchem Laboratories (Tianjin) Company Summary
7.18.2 Asymchem Laboratories (Tianjin) Business Overview
7.18.3 Asymchem Laboratories (Tianjin) One-stop Pharmacy Research CDMO Major Product Offerings
7.18.4 Asymchem Laboratories (Tianjin) One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.18.5 Asymchem Laboratories (Tianjin) Key News & Latest Developments
7.19 Beijing Sun-novo Pharmaceutical Research
7.19.1 Beijing Sun-novo Pharmaceutical Research Company Summary
7.19.2 Beijing Sun-novo Pharmaceutical Research Business Overview
7.19.3 Beijing Sun-novo Pharmaceutical Research One-stop Pharmacy Research CDMO Major Product Offerings
7.19.4 Beijing Sun-novo Pharmaceutical Research One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.19.5 Beijing Sun-novo Pharmaceutical Research Key News & Latest Developments
7.20 Arthur Pharma
7.20.1 Arthur Pharma Company Summary
7.20.2 Arthur Pharma Business Overview
7.20.3 Arthur Pharma One-stop Pharmacy Research CDMO Major Product Offerings
7.20.4 Arthur Pharma One-stop Pharmacy Research CDMO Revenue in Global Market (2018-2023)
7.20.5 Arthur Pharma Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
